Benzinga's Small Cap Movers for Thursday March 7, 2013 - InvestingChannel

Benzinga’s Small Cap Movers for Thursday March 7, 2013

Below are highlights from Benzinga’s daily coverage of small cap securities making big moves:

Sunshine Heart

Shares of Sunshine Heart (NASDAQ: SSH), the Eden Prairie, MN medical device company, rose almost 10% Thursday on 3 times average volume.

Sunshine Heart was the subject of a positive Seeking Alpha article on Thursday.

Sunshine Heart closed at $6.68 on Thursday.

China Information Technology China Information Technology (NASDAQ: CNIT), the China-based provider of information and display technologies, rose 36% Thursday on 10 times average volume.

There was no news to account for the strenght in China Information Technology on Thursday. China Information Technology closed at $1.38 on Thursday.

Affymax

Shares of Affymax (NASDAQ: AFFY), the Palo Alto, CA biopharmaceutical company, rose 53% Thursday on 17 times average volume.

Affymax surged higher on unusual option activity and reported comments by Fresenius Medical Care that they would be “open” to the possibility of Omontys return to market.

Affymax shares plummeted on February 25, after they and partner Takeda Pharmaceutical voluntarily recalled Omontys following reports of three deaths attributed to the anemia treatment for kidney dialysis patients.

Affymax closed at $3.52 on Thursday.

The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted in: Long Ideas, News, Short Ideas, FDA, Global, After-Hours Center, Movers, Trading Ideas